JH
Sen. John Hoeven (R-ND) bought $50K-$100K of BMY stock
John Hoeven, U.S. Senator (R-ND), disclosed a purchase of Bristol-Myers Squibb Company (BMY) stock worth $50K-$100K in a STOCK Act filing on Aug 29, 2016.
The trade happened on Aug 22, 2016, 7 days before it was made public.
BMY has moved +5.2% since the trade date, from $59.26 to $62.32 (Nov 12, 2026 close).
- Traded
- Aug 22, 2016
- Disclosed
- Aug 29, 2016
- Filing delay
- 7 days
- Price since
- +5.2%
- Source
- STOCK Act disclosure